Could a safe, side-effect-free antiparasitic drug be the breakthrough cancer treatment the world has been waiting for? In this bold, paradigm-shifting book, the founder of the influential Fenbendazole Can Cure Cancer Substack uncovers the revolutionary cancer-fighting potential of a surprising source: fenbendazole—a widely available, low-cost antiparasitic medication with decades of proven safety. Cancer is a Parasite offers a meticulously researched yet deeply personal journey into the science, case studies, and cutting-edge theories behind fenbendazole’s remarkable effects on cancer. With clarity and conviction, the author presents compelling evidence that cancer cells, like parasites, share a vulnerability in their microtubule structures—structures that fenbendazole is uniquely equipped to target. Unlike traditional chemotherapy, fenbendazole destroys cancer cells while leaving healthy cells untouched, offering a hopeful alternative without the toxic side effects. But this is more than a scientific exploration. It's a story of courage and survival, based on powerful real-world accounts of cancer patients who, after exhausting conventional treatments, turned to fenbendazole—and lived to tell their stories. From breast and prostate cancer to lung and brain tumors, their testimonies paint a hopeful picture of what’s possible when patients reclaim agency over their healing journeys. Blending groundbreaking research, emotional resilience, and a visionary new model that redefines cancer as a parasitic process, Cancer is a Parasite challenges the medical establishment and invites readers to see cancer—and its treatment—in an entirely new light. It is a powerful blueprint for a future where cancer could be not only treatable—but preventable.